Henry I Huang

Title: Innovations of Henry I Huang in HIV Treatment

Introduction

Henry I Huang is a notable inventor based in New York, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of proteins that are useful for treating HIV infections and tumors. With a total of 3 patents, his work has the potential to impact the lives of many individuals affected by these serious health conditions.

Latest Patents

Huang's latest patents include the development of an anti-HIV protein, TAP 29, derived from the plant Trichosanthes kirilowii. This protein is designed to be administered either alone or in conjunction with conventional AIDS therapies. The patent also details processes for purifying the protein, DNA sequences encoding the protein, and methods for expressing the protein using recombinant DNA techniques. Another significant patent involves a plant protein, MAP 30, which can be obtained from the fruit and seeds of Momordica charantia. This protein is also useful for treating tumors and HIV infections, with similar administration methods and purification processes outlined.

Career Highlights

Henry I Huang has worked with prestigious institutions such as New York University and American Biosciences, Inc. His research and innovations have garnered attention in the scientific community, contributing to advancements in medical treatments.

Collaborations

Huang has collaborated with notable colleagues, including Hsiang-fu Kung and Sylvia Lee-Huang. Their combined expertise has likely enhanced the research and development of the innovative treatments Huang has pioneered.

Conclusion

Henry I Huang's contributions to the field of biotechnology, particularly in the development of proteins for HIV treatment, showcase his dedication to improving health outcomes. His patents reflect a commitment to innovation that could lead to significant advancements in medical therapies.